Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles
Objective To review evidence regarding the prevalence, causation, clinical implications, aspects of healthcare utilisation and management of depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease. Design A critical review of the literature (1994–2009). Findings The...
Gespeichert in:
| Veröffentlicht in: | International journal of geriatric psychiatry 2010-12, Vol.25 (12), p.1209-1221 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1221 |
|---|---|
| container_issue | 12 |
| container_start_page | 1209 |
| container_title | International journal of geriatric psychiatry |
| container_volume | 25 |
| creator | Yohannes, A. M. Willgoss, T. G. Baldwin, R. C. Connolly, M. J. |
| description | Objective
To review evidence regarding the prevalence, causation, clinical implications, aspects of healthcare utilisation and management of depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease.
Design
A critical review of the literature (1994–2009).
Findings
The prevalence of depression and anxiety is high in both chronic obstructive pulmonary disease (8–80% depression; 6–74% anxiety) and chronic heart failure (10–60% depression; 11–45% anxiety). However, methodological weaknesses and the use of a wide range of diagnostic tools make it difficult to reach a consensus on rates of prevalence. Co‐morbid depression and anxiety are associated with increased mortality and healthcare utilisation and impact upon functional disability and quality of life. Despite these negative consequences, the identification and management of co‐morbid depression and anxiety in these two diseases is inadequate. There is some evidence for the positive role of pulmonary/cardiac rehabilitation and psychotherapy in the management of co‐morbid depression and anxiety, however, this is insufficient to guide recommendations.
Conclusions
The high prevalence and associated increase in morbidity and mortality justifies future research regarding the management of anxiety and depression in both chronic heart failure and chronic obstructive pulmonary disease. Current evidence suggests that multi‐faceted interventions such as pulmonary and cardiac rehabilitation may offer the best hope for improving outcomes for depression and anxiety. Copyright © 2009 John Wiley & Sons, Ltd. |
| doi_str_mv | 10.1002/gps.2463 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_856047475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017966570</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5143-d363ddf6e583be430964deb93c5388766249abb68778077251876e9f30d3da93</originalsourceid><addsrcrecordid>eNqFkl1r1jAUx4so7tkU_ARSBNELO5OmzcvuZNNHob6AA70LaXu6ZaZpTdptz8fxm3r2rNtAUC9CTnJ-5384L0nyhJJ9Skj--mSM-3nB2b1kRYlSGaWc309WRMoy4zkjO8lujGeEoI_Kh8lOTghjipSr5NcRjAFitINPjW_xXFqYNqn1aXMaBm-b9BRMmNLOWDcH2EI3nqGOU5ibyZ5DOs6uH7wJm7S1EUyEgxSFz40D38CrNIDDx9ZsnMVg41Lbjw6NCXPHrW5vvDmBHvyEsdY3dnQQHyUPOuMiPF7uveT43dvjw_dZ9Xn94fBNlTUlLVjWMs7atuNQSlZDwYjiRQu1Yk3JpBSc54Uydc2lEJIIkZcUP0F1jLSsNYrtJS-uZccw_JwhTrq3sQHnjIdhjlqWnBSiEOX_SSILTinhSL78J0kJFYrzUhBEn_2Bng1z8FiwllgeV0TIO70mDDEG6DS2qceeo5K-WgSNi6CvFgHRp4veXPfQ3oI3k0fg-QKYiMPoAg7HxjuOFQXFSpDLrrkL62Dz14R6_eXrknjhbZzg8pY34YfmgolSf_u01vm6qj5-r460Yr8Bz7faDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>814369078</pqid></control><display><type>article</type><title>Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Yohannes, A. M. ; Willgoss, T. G. ; Baldwin, R. C. ; Connolly, M. J.</creator><creatorcontrib>Yohannes, A. M. ; Willgoss, T. G. ; Baldwin, R. C. ; Connolly, M. J.</creatorcontrib><description>Objective
To review evidence regarding the prevalence, causation, clinical implications, aspects of healthcare utilisation and management of depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease.
Design
A critical review of the literature (1994–2009).
Findings
The prevalence of depression and anxiety is high in both chronic obstructive pulmonary disease (8–80% depression; 6–74% anxiety) and chronic heart failure (10–60% depression; 11–45% anxiety). However, methodological weaknesses and the use of a wide range of diagnostic tools make it difficult to reach a consensus on rates of prevalence. Co‐morbid depression and anxiety are associated with increased mortality and healthcare utilisation and impact upon functional disability and quality of life. Despite these negative consequences, the identification and management of co‐morbid depression and anxiety in these two diseases is inadequate. There is some evidence for the positive role of pulmonary/cardiac rehabilitation and psychotherapy in the management of co‐morbid depression and anxiety, however, this is insufficient to guide recommendations.
Conclusions
The high prevalence and associated increase in morbidity and mortality justifies future research regarding the management of anxiety and depression in both chronic heart failure and chronic obstructive pulmonary disease. Current evidence suggests that multi‐faceted interventions such as pulmonary and cardiac rehabilitation may offer the best hope for improving outcomes for depression and anxiety. Copyright © 2009 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0885-6230</identifier><identifier>ISSN: 1099-1166</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/gps.2463</identifier><identifier>PMID: 20033905</identifier><identifier>CODEN: IJGPES</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Anxiety ; Anxiety - complications ; Anxiety - epidemiology ; Anxiety - therapy ; Biological and medical sciences ; cardiac rehabilitation ; CHF ; Chronic Disease ; Chronic obstructive pulmonary disease ; Comorbidity ; COPD ; depression ; Depressive Disorder - complications ; Depressive Disorder - epidemiology ; Depressive Disorder - therapy ; Fundamental and applied biological sciences. Psychology ; General aspects ; Geriatric psychiatry ; Geriatrics ; Heart failure ; Heart Failure - psychology ; Heart Failure - rehabilitation ; Humans ; Intervention ; Medical sciences ; Mental depression ; Mental Health Services - utilization ; Morbidity ; Mortality ; New Zealand - epidemiology ; Prevalence ; Psychoanalysis ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychotherapy ; Pulmonary Disease, Chronic Obstructive - psychology ; Pulmonary Disease, Chronic Obstructive - rehabilitation ; pulmonary rehabilitation ; Quality of Life ; Rehabilitation</subject><ispartof>International journal of geriatric psychiatry, 2010-12, Vol.25 (12), p.1209-1221</ispartof><rights>Copyright © 2009 John Wiley & Sons, Ltd.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright John Wiley and Sons, Limited Dec 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5143-d363ddf6e583be430964deb93c5388766249abb68778077251876e9f30d3da93</citedby><cites>FETCH-LOGICAL-c5143-d363ddf6e583be430964deb93c5388766249abb68778077251876e9f30d3da93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fgps.2463$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fgps.2463$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>313,314,776,780,788,1411,27899,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23441808$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20033905$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yohannes, A. M.</creatorcontrib><creatorcontrib>Willgoss, T. G.</creatorcontrib><creatorcontrib>Baldwin, R. C.</creatorcontrib><creatorcontrib>Connolly, M. J.</creatorcontrib><title>Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles</title><title>International journal of geriatric psychiatry</title><addtitle>Int. J. Geriat. Psychiatry</addtitle><description>Objective
To review evidence regarding the prevalence, causation, clinical implications, aspects of healthcare utilisation and management of depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease.
Design
A critical review of the literature (1994–2009).
Findings
The prevalence of depression and anxiety is high in both chronic obstructive pulmonary disease (8–80% depression; 6–74% anxiety) and chronic heart failure (10–60% depression; 11–45% anxiety). However, methodological weaknesses and the use of a wide range of diagnostic tools make it difficult to reach a consensus on rates of prevalence. Co‐morbid depression and anxiety are associated with increased mortality and healthcare utilisation and impact upon functional disability and quality of life. Despite these negative consequences, the identification and management of co‐morbid depression and anxiety in these two diseases is inadequate. There is some evidence for the positive role of pulmonary/cardiac rehabilitation and psychotherapy in the management of co‐morbid depression and anxiety, however, this is insufficient to guide recommendations.
Conclusions
The high prevalence and associated increase in morbidity and mortality justifies future research regarding the management of anxiety and depression in both chronic heart failure and chronic obstructive pulmonary disease. Current evidence suggests that multi‐faceted interventions such as pulmonary and cardiac rehabilitation may offer the best hope for improving outcomes for depression and anxiety. Copyright © 2009 John Wiley & Sons, Ltd.</description><subject>Anxiety</subject><subject>Anxiety - complications</subject><subject>Anxiety - epidemiology</subject><subject>Anxiety - therapy</subject><subject>Biological and medical sciences</subject><subject>cardiac rehabilitation</subject><subject>CHF</subject><subject>Chronic Disease</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>COPD</subject><subject>depression</subject><subject>Depressive Disorder - complications</subject><subject>Depressive Disorder - epidemiology</subject><subject>Depressive Disorder - therapy</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General aspects</subject><subject>Geriatric psychiatry</subject><subject>Geriatrics</subject><subject>Heart failure</subject><subject>Heart Failure - psychology</subject><subject>Heart Failure - rehabilitation</subject><subject>Humans</subject><subject>Intervention</subject><subject>Medical sciences</subject><subject>Mental depression</subject><subject>Mental Health Services - utilization</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>New Zealand - epidemiology</subject><subject>Prevalence</subject><subject>Psychoanalysis</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychotherapy</subject><subject>Pulmonary Disease, Chronic Obstructive - psychology</subject><subject>Pulmonary Disease, Chronic Obstructive - rehabilitation</subject><subject>pulmonary rehabilitation</subject><subject>Quality of Life</subject><subject>Rehabilitation</subject><issn>0885-6230</issn><issn>1099-1166</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl1r1jAUx4so7tkU_ARSBNELO5OmzcvuZNNHob6AA70LaXu6ZaZpTdptz8fxm3r2rNtAUC9CTnJ-5384L0nyhJJ9Skj--mSM-3nB2b1kRYlSGaWc309WRMoy4zkjO8lujGeEoI_Kh8lOTghjipSr5NcRjAFitINPjW_xXFqYNqn1aXMaBm-b9BRMmNLOWDcH2EI3nqGOU5ibyZ5DOs6uH7wJm7S1EUyEgxSFz40D38CrNIDDx9ZsnMVg41Lbjw6NCXPHrW5vvDmBHvyEsdY3dnQQHyUPOuMiPF7uveT43dvjw_dZ9Xn94fBNlTUlLVjWMs7atuNQSlZDwYjiRQu1Yk3JpBSc54Uydc2lEJIIkZcUP0F1jLSsNYrtJS-uZccw_JwhTrq3sQHnjIdhjlqWnBSiEOX_SSILTinhSL78J0kJFYrzUhBEn_2Bng1z8FiwllgeV0TIO70mDDEG6DS2qceeo5K-WgSNi6CvFgHRp4veXPfQ3oI3k0fg-QKYiMPoAg7HxjuOFQXFSpDLrrkL62Dz14R6_eXrknjhbZzg8pY34YfmgolSf_u01vm6qj5-r460Yr8Bz7faDw</recordid><startdate>201012</startdate><enddate>201012</enddate><creator>Yohannes, A. M.</creator><creator>Willgoss, T. G.</creator><creator>Baldwin, R. C.</creator><creator>Connolly, M. J.</creator><general>John Wiley & Sons, Ltd</general><general>Psychology Press</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope></search><sort><creationdate>201012</creationdate><title>Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles</title><author>Yohannes, A. M. ; Willgoss, T. G. ; Baldwin, R. C. ; Connolly, M. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5143-d363ddf6e583be430964deb93c5388766249abb68778077251876e9f30d3da93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anxiety</topic><topic>Anxiety - complications</topic><topic>Anxiety - epidemiology</topic><topic>Anxiety - therapy</topic><topic>Biological and medical sciences</topic><topic>cardiac rehabilitation</topic><topic>CHF</topic><topic>Chronic Disease</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>COPD</topic><topic>depression</topic><topic>Depressive Disorder - complications</topic><topic>Depressive Disorder - epidemiology</topic><topic>Depressive Disorder - therapy</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General aspects</topic><topic>Geriatric psychiatry</topic><topic>Geriatrics</topic><topic>Heart failure</topic><topic>Heart Failure - psychology</topic><topic>Heart Failure - rehabilitation</topic><topic>Humans</topic><topic>Intervention</topic><topic>Medical sciences</topic><topic>Mental depression</topic><topic>Mental Health Services - utilization</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>New Zealand - epidemiology</topic><topic>Prevalence</topic><topic>Psychoanalysis</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychotherapy</topic><topic>Pulmonary Disease, Chronic Obstructive - psychology</topic><topic>Pulmonary Disease, Chronic Obstructive - rehabilitation</topic><topic>pulmonary rehabilitation</topic><topic>Quality of Life</topic><topic>Rehabilitation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yohannes, A. M.</creatorcontrib><creatorcontrib>Willgoss, T. G.</creatorcontrib><creatorcontrib>Baldwin, R. C.</creatorcontrib><creatorcontrib>Connolly, M. J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yohannes, A. M.</au><au>Willgoss, T. G.</au><au>Baldwin, R. C.</au><au>Connolly, M. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int. J. Geriat. Psychiatry</addtitle><date>2010-12</date><risdate>2010</risdate><volume>25</volume><issue>12</issue><spage>1209</spage><epage>1221</epage><pages>1209-1221</pages><issn>0885-6230</issn><issn>1099-1166</issn><eissn>1099-1166</eissn><coden>IJGPES</coden><abstract>Objective
To review evidence regarding the prevalence, causation, clinical implications, aspects of healthcare utilisation and management of depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease.
Design
A critical review of the literature (1994–2009).
Findings
The prevalence of depression and anxiety is high in both chronic obstructive pulmonary disease (8–80% depression; 6–74% anxiety) and chronic heart failure (10–60% depression; 11–45% anxiety). However, methodological weaknesses and the use of a wide range of diagnostic tools make it difficult to reach a consensus on rates of prevalence. Co‐morbid depression and anxiety are associated with increased mortality and healthcare utilisation and impact upon functional disability and quality of life. Despite these negative consequences, the identification and management of co‐morbid depression and anxiety in these two diseases is inadequate. There is some evidence for the positive role of pulmonary/cardiac rehabilitation and psychotherapy in the management of co‐morbid depression and anxiety, however, this is insufficient to guide recommendations.
Conclusions
The high prevalence and associated increase in morbidity and mortality justifies future research regarding the management of anxiety and depression in both chronic heart failure and chronic obstructive pulmonary disease. Current evidence suggests that multi‐faceted interventions such as pulmonary and cardiac rehabilitation may offer the best hope for improving outcomes for depression and anxiety. Copyright © 2009 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>20033905</pmid><doi>10.1002/gps.2463</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-6230 |
| ispartof | International journal of geriatric psychiatry, 2010-12, Vol.25 (12), p.1209-1221 |
| issn | 0885-6230 1099-1166 1099-1166 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_856047475 |
| source | MEDLINE; Wiley Online Library |
| subjects | Anxiety Anxiety - complications Anxiety - epidemiology Anxiety - therapy Biological and medical sciences cardiac rehabilitation CHF Chronic Disease Chronic obstructive pulmonary disease Comorbidity COPD depression Depressive Disorder - complications Depressive Disorder - epidemiology Depressive Disorder - therapy Fundamental and applied biological sciences. Psychology General aspects Geriatric psychiatry Geriatrics Heart failure Heart Failure - psychology Heart Failure - rehabilitation Humans Intervention Medical sciences Mental depression Mental Health Services - utilization Morbidity Mortality New Zealand - epidemiology Prevalence Psychoanalysis Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychotherapy Pulmonary Disease, Chronic Obstructive - psychology Pulmonary Disease, Chronic Obstructive - rehabilitation pulmonary rehabilitation Quality of Life Rehabilitation |
| title | Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T10%3A11%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depression%20and%20anxiety%20in%20chronic%20heart%20failure%20and%20chronic%20obstructive%20pulmonary%20disease:%20prevalence,%20relevance,%20clinical%20implications%20and%20management%20principles&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Yohannes,%20A.%20M.&rft.date=2010-12&rft.volume=25&rft.issue=12&rft.spage=1209&rft.epage=1221&rft.pages=1209-1221&rft.issn=0885-6230&rft.eissn=1099-1166&rft.coden=IJGPES&rft_id=info:doi/10.1002/gps.2463&rft_dat=%3Cproquest_cross%3E1017966570%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=814369078&rft_id=info:pmid/20033905&rfr_iscdi=true |